Related Experiment Videos
[Clinical evaluation of incomplete PTCA revascularization efficacy]
B Norwa-Otto1, M Dabrowski, A Debski
1Kliniki Kardiologii Ogólnej i II Samodzielnej Pracowni Hemodynamicznej Instytutu Kardiologii, Warszawie.
Kardiologia Polska
|January 1, 1991
Summary
Incomplete percutaneous transluminal coronary angioplasty (PTCA) revascularization offers satisfactory long-term outcomes for most multivessel disease (MVD) patients. However, it serves as a palliative measure for high-risk surgical candidates with complex MVD.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Multivessel disease (MVD) presents complex revascularization challenges.
- Percutaneous transluminal coronary angioplasty (PTCA) is a common intervention for MVD.
- Incomplete revascularization (IR) strategies require careful evaluation of long-term results.
Purpose of the Study:
- To assess the long-term clinical outcomes of incomplete PTCA revascularization in patients with multivessel disease.
- To stratify outcomes based on different types of incomplete revascularization.
- To determine the efficacy of IR in managing complex coronary artery disease.
Main Methods:
- Retrospective analysis of 89 patients with multivessel disease undergoing incomplete PTCA revascularization.
- Patients were categorized into four groups (Type A, B, C, D) based on stenosis severity and location.
- Follow-up assessment included angina status and need for coronary bypass surgery at an average of 17.7 months.
Main Results:
- 64.1% of patients were completely free of angina at follow-up.
- 25.8% experienced only mild effort angina.
- 10.1% required subsequent coronary bypass surgery, predominantly in the high-risk Type D group.
Conclusions:
- Incomplete PTCA revascularization yields satisfactory long-term results for patients with Type A, B, and C MVD.
- IR acts as a palliative approach for high-risk surgical patients with Type D MVD, offering potential clinical benefits in select cases.